Abstract: The invention provides vitamin k-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
Type:
Application
Filed:
May 27, 2004
Publication date:
November 4, 2004
Applicant:
Regents of the University of Minnesota, a MN corporation